Efficacy of duloxetine in painful symptoms with major depressive disorder

被引：0
|
作者：
Castano, J. [1 ]
Garnier, C. [1 ]
Corcoles, D. [1 ]
Rodriguez, L. [1 ]
Diaz, B. [1 ]
Martin, L. M. [1 ]
Bulbena, A. [1 ]
机构：
[1] Hosp del Mar, Primary Psychiat Unit, IAPS, Barcelona, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70400-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S298 / S299
页数：2
相关论文
共 50 条
  • [21] Pharmacotherapy of Major Depressive Disorder: Focus on Duloxetine
    Muneoka, Katsumasa
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1541 - 1556
  • [22] An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
    Kuga, Atsushi
    Tsuji, Toshinaga
    Hayashi, Shinji
    Matsubara, Mako
    Fujikoshi, Hinji
    Tokuoka, Hirofumi
    Yoshikawa, Aki
    Escobar, Rodrigo
    Tanaka, Kazuhide
    Azekawa, Takaharu
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2105 - 2114
  • [23] Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia, David G. S.
    Pritchett, Yili L.
    Desaiah, Durisala
    Raskin, Joel
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (06) : 311 - 317
  • [24] A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical
    Gaynor, Paula J.
    Gopal, Murali
    Zheng, Wei
    Martinez, James M.
    Robinson, Michael J.
    Marangell, Lauren B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1849 - 1858
  • [25] Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant painful physical symptoms
    Weisberg, R.
    Fava, M.
    Hartford, J.
    Erickson, J.
    D'Souza, D.
    Russell, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S118 - S118
  • [26] Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant painful physical symptoms
    Weisberg, R.
    Fava, M.
    Hartford, J.
    Erickson, J.
    D'Souza, D.
    Lledo, A.
    Russell, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 138 - 138
  • [27] Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
    Mallinckrodt, Craig H.
    Watkin, John G.
    Liu, Chaofeng
    Wohlreich, Madelaine M.
    Raskin, Joel
    BMC PSYCHIATRY, 2005, 5 (1)
  • [28] Association of Additional Common Variants in COMT with Duloxetine Efficacy in Patients with Major Depressive Disorder
    Houston, John P.
    Kohler, Jared
    Ostbye, Katherine M.
    Heinloth, Alexandra N.
    Perlis, Roy
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 184S - 184S
  • [29] Duloxetine in the treatment of major depressive disorder: A comparison of efficacy in patients with and without melancholic features
    Mallinckrodt, CH
    Watkin, JG
    Liu, C
    Wohlreich, MM
    Raskin, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S175 - S175
  • [30] Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder
    Schatzberg, AF
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 : 30 - 37
12345